$ILMN
AI 分析生成於 May 11, 2026
AI Score
Hold$ILMN
Illumina Inc.
$ILMNNASDAQHealthcareLarge-Cap
Illumina develops sequencing and array-based technologies for genetic analysis in research, clinical, and applied markets.
Market Cap
$18.0B
Revenue (TTM)
$4.5B
+3.0%
Net Income (TTM)
$0.3B
+40.0%
EPS (TTM)
$1.85
P/E Ratio
72.0
Dividend Yield
0.0%
52-Week Range
$95-$155
Beta
1.25
Dimension Scores
Fundamental
55Technical
52Sentiment
60Risk / Reward
56Momentum
58Financial Health
Profitability
60moderate
Growth
61moderate
Liquidity
64strong
Solvency
57moderate
Efficiency
53moderate
Valuation, technical analysis, investment thesis, risk assessment and more for $ILMN
Free · No credit card required
免責聲明: AI 生成的分析僅供教育參考,不構成投資建議。請始終諮詢合格的理財顧問。